Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer
Annals of Surgical Oncology - 2016
Masato Kataoka1, Mitsuro Kanda2, Kiyoshi Ishigure3, Hiroshi Matsuoka4, Yusuke Sato5, Tsuyoshi Takahashi6, Chihiro Tanaka7, Tomohiro Deguchi8, Yoshihisa Shibata9, Mikinori Sato10, Hitoshi Inagaki11, Takanori Matsui12, Akinobu Kondo13, Nao Takano2, Haruyoshi Tanaka2, Junichi Sakamoto14, Koji Oba15,16, Ken Kondo1
1Department of Surgery, Nagoya National Hospital, Nagoya, Japan
2Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
3Department of Surgery, Konan Kosei Hospital, Konan, Japan
4Department of Surgery, Fujita Health University, School of Medicine, Aichi, Japan
5Department of Surgery, Tosei Hospital, Seto, Japan
6Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, Japan
7Department of Surgery, Gifu Prefectural General Medical Center, Gifu, Japan
8Department of Surgery, Gifu Prefectural Tajimi Hospital, Tajimi, Japan
9Department of Surgery, Toyohashi Municipal Hospital, Toyohashi, Japan
10Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
11Department of Surgery, Yokoyama Hospital for Gastroenterological Diseases, Nagoya, Japan
12Department of Gastroenterological Surgery, Aichi Cancer Center Aichi Hospital, Okazaki, Japan
13Department of Surgery, Saiseikai Matsusaka General Hospital, Matsusaka, Japan
14Tokai Central Hospital, Gifu, Japan
15Interfaculty Initiative in Information Studies, Tokyo University, Tokyo, Japan
16Department of Biostatistics, School of Public Health, Tokyo University Graduate School of Medicine, Tokyo, Japan